Babson Diagnostics, a science-first healthcare technology company, today announced that BetterWay™ blood testing is a ...

Pharma dealmaking for drugs invented in China is putting pressure on U.S. biotechs to compete harder, according to investors ...

It’s a kind of control that no one has ever tried before in patients,” Tune’s chief scientific officer said Monday.

Atalanta Therapeutics is building on the growing attention around RNAi-based medicines with its $97 million Series B financing and plans to enter the clinic.

The U.S. Commerce Department said Wednesday it is imposing new export controls on biotechnology equipment and related technology because of national security concerns tied to artificial intelligence ...

We recently published a list of the 12 Biotech Stocks with the Biggest Upside ... potential and pose an “option-like structure” if clinical trials succeed. This makes them especially ...

Today, ZAGENO, the leading AI-powered marketplace for lab supplies, and Hatch.Bio Labs, a premier biotech incubator, join forces to eliminate these challenges. This strategic partnership empowers ...

We recently compiled a list of the 10 Hottest Smid-Cap Stocks So Far In 2025. In this article, we are going to take a look at ...

Inc. (Aurion Biotech), whose mission is to restore vision to millions of patients with life-changing regenerative therapies, today announced topline data from its Phase 1/2 clinical trial (CLARA ...